Who to call at BioStem Technologies, Inc., and when
Fundz watches for the moments BioStem Technologies, Inc. starts buying, and tells you who to reach.
- An alert the day BioStem Technologies, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioStem Technologies, Inc., from your own LinkedIn network
BioStem Technologies, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
www.biostemtechnologies.comAI Executive Summary
AI-powered analysis of 8-K filing content
BioStem Technologies completed a private placement on September 29, 2026, raising approximately $3.0 million by issuing 735,296 shares of common stock at $4.08 per share, along with Series A and Series B warrants. This funding strengthens the company's financial position to support operations and strategic growth initiatives.
Key Takeaways
BioStem raised $2,999,999.68 through private placement of 735,296 common shares at $4.08 per share
Investors received Series A and Series B warrants exercisable at $3.83 per share for up to 735,296 shares each
2 more takeaways
Related Filings (2)
2 more filings from BioStem Technologies, Inc. in the last 90 days
Filing Overview
What This Means
BioStem Technologies, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.